Skip to content
Nonprofiteer
← CONGENITAL HYPERINSULINISM INTERNATIONAL

Form 990 for tax year 2023

Filed by CONGENITAL HYPERINSULINISM INTERNATIONAL.

Totals

Total revenue
$1,150,291
Total expenses
$1,043,446
Contributions and grants received
$463,103
Grants paid
$88,125
Program service revenue
$694,586
Investment income
$25,235
Other revenue
-$32,633
Total assets, end of year
$1,803,323
Total liabilities, end of year
$98,789
Net assets or fund balances, end of year
$1,704,534
Program services expenses (Part IX)
$919,830
Management and general expenses
$41,912
Fundraising expenses
$81,704
Program service expenses (Part III)
$919,830

Program services were 88.2% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1c , Fundraising events

    $174,266

  • 1f , All other contributions, gifts and grants

    $288,837

  • 2a , Program service revenue: CONFERENCES

    total $235,645 · excluded $235,645

  • 2b , Program service revenue: RESEARCH

    total $458,941 · excluded $458,941

  • 3 , Investment income

    total $25,235 · related or exempt $25,235

  • 4 , Income from investment of tax-exempt bond proceeds

    total $0

  • 5 , Royalties

    total $0

  • 6d , Net rental income or loss

    total $0

  • 7d , Net gain or loss

    total $0

  • 8a , Fundraising events: gross income

    $33,000

  • 8a , Fundraising events: contributions included on line 1c

    $174,266

  • 8b , Fundraising events: direct expenses

    $66,450

  • 8c , Net income from fundraising events

    total -$33,450

  • 9c , Net income from gaming

    total $0

  • 10c , Net income from sales of inventory

    total $0

  • 11a , Other revenue: Misc revenue

    total $817 · related or exempt $817

  • 11e , Other revenue, total

    $817

Functional expenses

Part IX, the statement of functional expenses.

  • 1 , Grants to domestic organizations and governments

    total $41,650 · program services $41,650

  • 2 , Grants to domestic individuals

    total $0

  • 3 , Grants to foreign organizations and individuals

    total $46,475 · program services $46,475

  • 4 , Benefits paid to or for members

    total $0

  • 5 , Compensation of officers, directors and key employees

    total $269,704 · program services $232,042 · management and general $17,185 · fundraising $20,477

  • 6 , Compensation of disqualified persons

    total $0

  • 7 , Other salaries and wages

    total $170,143 · program services $140,360 · fundraising $29,783

  • 8 , Pension plan contributions

    total $0

  • 9 , Other employee benefits

    total $17,185 · program services $14,551 · management and general $670 · fundraising $1,964

  • 10 , Payroll taxes

    total $38,046 · program services $32,211 · management and general $1,488 · fundraising $4,347

  • 11a , Fees: management

    total $0

  • 11b , Fees: legal

    total $0

  • 11c , Fees: accounting

    total $19,129 · program services $3,177 · management and general $12,776 · fundraising $3,176

  • 11d , Fees: lobbying

    total $0

  • 11e , Fees: professional fundraising services

    total $0

  • 11f , Fees: investment management

    total $0

  • 11g , Fees: other

    total $28,568 · program services $18,568 · fundraising $10,000

  • 12 , Advertising and promotion

    total $0

  • 13 , Office expenses

    total $12,345 · program services $5,343 · management and general $3,631 · fundraising $3,371

  • 14 , Information technology

    total $0

  • 15 , Royalties

    total $0

  • 16 , Occupancy

    total $392 · program services $317 · management and general $37 · fundraising $38

  • 17 , Travel

    total $26,555 · program services $26,555

  • 18 , Travel or entertainment for public officials

    total $0

  • 19 , Conferences, conventions and meetings

    total $219,968 · program services $219,968

  • 20 , Interest

    total $0

  • 21 , Payments to affiliates

    total $0

  • 22 , Depreciation, depletion and amortization

    total $1,875 · program services $1,875

  • 23 , Insurance

    total $5,963 · program services $2,391 · management and general $1,755 · fundraising $1,817

  • 24a , Other expenses: PROGRAM COSTS AND MATERIALS

    total $99,149 · program services $99,149

  • 24b , Other expenses: TELECOMMUNICATION & TECHNOLOGY

    total $18,061 · program services $8,843 · management and general $3,723 · fundraising $5,495

  • 24c , Other expenses: PROJECT EXPENSES

    total $16,911 · program services $16,911

  • 24d , Other expenses: DUES AND SUBSCRIPTIONS

    total $6,130 · program services $5,517 · management and general $307 · fundraising $306

  • 24e , All other expenses

    total $5,197 · program services $3,927 · management and general $340 · fundraising $930

Balance sheet

Part X, book values.

  • 1 , Cash, non-interest-bearing

    beginning of year $1,510,108 · end of year $1,595,342

  • 2 , Savings and temporary cash investments

    end of year $0

  • 3 , Pledges and grants receivable

    beginning of year $116,060 · end of year $64,759

  • 4 , Accounts receivable

    end of year $0

  • 5 , Loans and receivables from officers and key people

    end of year $0

  • 6 , Loans and receivables from disqualified persons

    end of year $0

  • 7 , Other notes and loans receivable

    end of year $0

  • 8 , Inventories for sale or use

    end of year $0

  • 9 , Prepaid expenses and deferred charges

    beginning of year $18,147 · end of year $31,746

  • 10c , Land, buildings and equipment, net

    end of year $0

  • 11 , Investments: publicly traded securities

    end of year $0

  • 12 , Investments: other securities

    end of year $0

  • 13 , Investments: program-related

    end of year $0

  • 14 , Intangible assets

    end of year $111,476

  • 15 , Other assets

    end of year $0

  • 17 , Accounts payable and accrued expenses

    beginning of year $46,626 · end of year $98,789

  • 27 , Net assets without donor restrictions

    beginning of year $1,562,689 · end of year $1,669,534

  • 28 , Net assets with donor restrictions

    beginning of year $35,000 · end of year $35,000

Mission and programs · 2023

Mission

Congenital Hyperinsulinism International (CHI) is dedicated to creating awareness, providing support and the advancement of research to improve the lives of those impacted by congenital hyperinsulinism and other rare hypoglycemia disorders globally. CHI provides education, information and support to families of diagnosed children and adults living with the consequences of the condition. CHI works to promote knowledge and awareness of the disorder as it leads to timely diagnosis and decreases death and brain damage, better care and better neurological outcomes. CHI supports research and development for a better understanding of the condition, leading to a better quality of life, better treatments and management of the condition, and ultimately, a cure.

Activities or mission (Part I)

Congenital Hyperinsulinism International's mission is to improve the lives of people living with congenital hyperinsulinism (or its consequences),a disorder that causes severe hypoglycemia that can lead to seizures,brain damage,or death, if untreated.

  • CHI supports research and development to better understand, treat, manage and hopefully cure HI. CHI shares the patient perspective with researchers and members of the biopharmaceutical industry to accelerate the development of patient-centered treatments. CHI is part of the Million Dollar Bike Ride grant program with the University of Pennsylvania's Center for Orphan Diseases; a pilot research grant is offered each year for an innovative, preclinical or clinical study with the potential to lead to a better HI treatment, a cure for HI, or improvement in the quality of life for those affected by HI. CHI conducts the HI Global Registry (HIGR) research project. HIGR provides a convenient online platform for the HI patient community to share their experiences of living with HI. With permission from the patient families, MaxHIGR provides complementary data from the physician perspective. By participating in the HI Global Registry, the patient community helps themselves and researchers better understand HI to advance better treatments, a potential cure, and more timely and accurate diagnoses. A HIGR report is published each year by the CHI staff. Scholars and researchers may request deidentified data for their research projects. In 2023, CHI continued to lead the Collaborative Research Network (CRN), , a project of CHI dedicated to the development of faster and more accurate diagnoses, new evidence-based treatments and cures, standardized clinical guidelines, and increased and improved access to treatment, medication, devices, and supplies. This ambitious project includes working groups focused on different aspects of a prioritized research agenda (PRA) developed by the CRNs members including 55 leading researchers, clinicians, and patient advocates from 16 countries The CRN members have been focused on the top priorities identified in the PRA: Newborn Screening (Diagnose all babies with congenital hyperinsulinism in a timely manner); Glucose as a Vital Sign (Increase awareness and timely diagnosis of HI); Care Guidelines (Create and disseminate continually evolving global care guidelines); Natural History (Build a robust registry that collects patient-reported, physician, and real-world data to provide a foundation for HI natural history); Continuous Glucose Monitoring (Create principles for Draft guidelines on CGM use in HI patients)The first-ever international hyperinsulinism guidelines were published in July 2023. These guidelines are a collaboration of work by HI experts around the world, including many who are part of the CHI Collaborative Research Network and CHI staff. Patient and caregiver representatives of the CHI Congenital Hyperinsulinism Collaborative Research Network provided the patient perspective. CHI continues to support the Open Hyperinsulinism Genes Program in partnership with the University of Exeter in the UK which is the first point-of-need international genetic testing service for HI that is also accelerating scientific knowledge through the creation of a self-sustaining, research gene discovery pipeline. Through December 2023, 894 samples from individuals affected by Congenital Hyperinsulinism and 630 samples from family members from 61 countries on 5 continents have been tested. In 2023, CHI continued to support the CHI Centers of Excellence Designation. Six centers were granted the designation and recognized as multi-disciplinary clinical and research centers in the field of congenital hyperinsulinism in 2021. The goals of this program are to make it easier for patient families to access care at leading hospitals, encourage patient-focused standards at the leading hospitals, foster a pipeline of expert clinicians and researchers, and to encourage collaboration among researchers, clinicians, and patient leaders and advocates.

    Expenses $423,589

  • CHI advocates on behalf of HI families all over the world for access to quality treatment, medication, and supplies. CHI provides opportunities for affected families to emotionally support each other because the home care medical management of HI is often complicated and difficult. CHI offers online forums, and CHI staff and volunteers are available by telephone, online and in-person for support. CHI establishes funds at hospitals to support families from out of town who must travel to centers of excellence for patient care.

    Expenses $274,496

  • CHI increases awareness of HI in order to improve timely diagnosis among the public and medical personnel who have a direct opportunity to detect it, to decrease adverse neurological outcomes and death. To that end, CHI spreads awareness of HI with ongoing campaigns on social media, the CHI website and blog, CHI posters in 24 languages, CHI brochures, through direct mail and email, and at meetings and conferences. CHI provides educational resources and holds onferences and meetings on HI for patients, families, medical professionals, school personnel,and rare disease industry members. To date, CHI has held 31 family and research meetings and conferences with presentations from academic researchers, members of advocacy organizations, HI patients and families, and biotechnology companies.

    Expenses $221,745

As filed on the 2023 return.

Listed in Part VII

  • Julie Raskin

    CEO

    Total calculated
    $103,704
    From this org
    $103,704
    From related orgs
    $0
    Other
    $0
    Hours/week
    40
  • Tai Pasquini

    CRO

    Total calculated
    $86,000
    From this org
    $86,000
    From related orgs
    $0
    Other
    $0
    Hours/week
    40
  • Jennifer Schmitt

    COO

    Total calculated
    $80,000
    From this org
    $80,000
    From related orgs
    $0
    Other
    $0
    Hours/week
    40
  • Sheila Bose

    President

    Total calculated
    $0
    Hours/week
    6
  • Turaya Bryant Kamau

    Secretary

    Total calculated
    $0
    Hours/week
    1
  • Erin Greaves

    Director

    Total calculated
    $0
    Hours/week
    1
  • Laura Sullivan

    Director

    Total calculated
    $0
    Hours/week
    1
  • Mason Smith

    Treasurer

    Total calculated
    $0
    Hours/week
    2
  • Pam Williams

    Director

    Total calculated
    $0
    Hours/week
    1
  • Julie Sheldon

    Vice President

    Total calculated
    $0
    Hours/week
    1

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.

Grants on this return

  • UNIVERSITY OF PENNSYLVANIA

    $31,650

    RESEARCH

Fundraising and gaming

From Schedule G of this return, as filed.

Had an agreement with a professional fundraiser (line 2a)
No

Fundraising events (Part II)

Part II has at most four columns: the two largest events, the rest together, and the total.

Fundraising events (Part II)
Line Event 1 SUGAR SOIREE Total
Gross receipts (line 1) $207,266 $207,266
Less contributions (line 2) $174,266 $174,266
Gross income (line 3) $33,000 $33,000
Cash prizes (line 4) — —
Noncash prizes (line 5) — —
Rent and facility costs (line 6) $66,450 $66,450
Food and beverages (line 7) — —
Entertainment (line 8) — —
Other direct expenses (line 9) — —
Direct expenses (line 10)
$66,450
Net income (line 11)
-$33,450

Activities outside the United States

From Schedule F of this return, as filed.

At most 25 lines of each part are listed here. Schedule F names no grantee, so each line is a region and its money.

Grants to organizations, by region (Part II)

The purpose of each grant is not shown.

Grants to organizations, by region (Part II)
Region Cash grants Manner of disbursement Noncash assistance Noncash description Valuation
SRI LANKA $7,369 Wire — — —
UK $34,106 Wire — — —
Grantees recognized as charities or with a 501(c)(3) equivalency letter (Part II line 2)
—
Other grantees (Part II line 3)
2
Transferred property to a foreign corporation during the year (line 1)
No
Had an interest in a foreign trust (line 2)
No
Owned an interest in a foreign corporation (line 3)
No
Was a shareholder of a passive foreign investment company or qualified electing fund (line 4)
No
Owned an interest in a foreign partnership (line 5)
No
Had operations in or related to a boycotting country (line 6)
No

Provenance

Return type
form_990
Tax year
2023
Filed
8 October 2024
IRS schema version
2023v5.1
Source object
202402869349300315

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.